Sort
23,748 grants matching “melanoma”
Human Immunology Core
$209,846Eline Tjetske Luning Prak · University Of Pennsylvania · P30 · FY2019 · CA
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
$209,793Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2021 · CA
Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A
$209,674Guojun Wang · Florida Atlantic University · R21 · FY2016 · CA
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities
$209,670Brent Allen Hanks · Duke University · R01 · FY2024 · CA
Autophagy in epidermal melanocyte: a protective or a destructive role?
$209,651Vijayasaradhi Setaluri · University Of Wisconsin-Madison · R21 · FY2012 · AR
Human Immunology Core
$209,644Eline Tjetske Luning Prak · University Of Pennsylvania · P30 · FY2020 · CA
Role of AhR/Arnt Signaling Pathway in Carcinogenesis
$209,641Lori A White · Rutgers, The State Univ Of N.J. · R01 · FY2007 · ES
Administration and Clinical Trials
$209,543Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2014 · CA
IL-12 GENE THERAPY TO PRIME AND REPOLARIZE ANTI-TUMOR TH1-TYPE T CELLS
$209,525Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTES
$209,474University Of Cincinnati · R01 · FY2001 · AR
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting
$209,463Frank Markus · Brigham And Women'S Hospital · P50 · FY2008 · CA
Synergistic innate immune activation and cell killing by RIG-I ligands in HCV-HCC
$209,453Lee Gehrke · Massachusetts Institute Of Technology · R21 · FY2012 · CA
Regulation of TRAF2 Activity in Normal and Tumor Cells
$209,450Hasem Habelhah · University Of Iowa · R01 · FY2006 · CA
Pilot Projects and Trans-Network Activities Core
$209,424Meenhard Herlyn · Wistar Institute · U54 · FY2021 · CA
Pilot Projects and Trans-Network Activities Core
$209,424Meenhard Herlyn · Wistar Institute · U54 · FY2020 · CA
ROLE OF HLA ALLELES AND CYTOKINES IN MELANOMA PROGNOSIS
$209,408Jeffrey E Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Development of BBB Permeable PD-L1 PET Imaging Agents
$209,375Zhengxin Cai · Yale University · R21 · FY2020 · EB
Naïve T cell archetypes and anti-tumor immunity
$209,375Carla Rothlin · Yale University · R21 · FY2024 · AI
Host factors and inhibition of Filoviruses
$209,375Anne Goldfeld · Boston Children'S Hospital · R21 · FY2021 · AI
IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER
$209,371University Of Alabama At Birmingham · R01 · FY2002 · CA
Keratinocyte targeted strategies for treatment of cutaneous GVHD
$209,344Yunyan Jennifer Jennifer Zhang · Duke University · R21 · FY2019 · CA
Early Detection and Immunomodulation of PD-1 Inhibitor Induced Cardiotoxicity
$209,275Saraswati Pokharel · Roswell Park Cancer Institute Corp · R21 · FY2021 · HL
Core B: Biospecimen Core
$209,255Ruth Halaban · Yale University · P50 · FY2024 · CA
Metabolic Engineering of Cancer for Immunotargeting
$209,235Zhongwu Guo · Wayne State University · R01 · FY2011 · CA
Metabolic Engineering of Cancer for Immunotargeting
$209,235Zhongwu Guo · Wayne State University · R01 · FY2012 · CA